Amy Tang
About Amy Tang
Amy Thorne - Vice President of Preclinical Research and Development
Amy Thorne holds the position of Vice President of Preclinical Research and Development. In this role, she oversees the planning and implementation of preclinical studies, ensuring their alignment with the organization's broader research and development goals. Her responsibilities include leading a team of researchers, managing project timelines, and coordinating the necessary resources to advance the company's preclinical initiatives.
Amy Thorne's Co-authored Study on Photoimmunotherapy
Amy Thorne co-authored a study focusing on the reduction of photoimmunotherapy-induced edema through the inhibition of COX-2. This research explores the potential benefits of COX-2 inhibitors in mitigating side effects associated with photoimmunotherapy, a technique used in cancer treatment. The findings contribute to a better understanding of how to improve therapeutic outcomes and patient comfort during treatment.